4 minBusiness
Oura Files for IPO, Seeking $2.2 Billion at $15.62 Billion Valuation
Finnish smart-ring maker Oura has publicly filed for an initial public offering, with shareholders aiming to raise up to $2.2 billion in a listing that values the company at roughly $15.62 billion and sets the stage for a busy fall IPO season in the United States.
Oura, the Finnish maker of health-tracking smart rings, has publicly filed for an initial public offering in the United States, with shareholders seeking to raise up to $2.2 billion. The listing would value the company at approximately $15.62 billion, according to the terms disclosed in the filing.
The move marks a significant step for a company that has built a following by putting health monitoring into a piece of jewelry rather than a wrist-worn device. Oura's rings track sleep, recovery, heart rate and other biometric signals, and the company has positioned itself at the intersection of consumer electronics and personal health.
The offering is being launched by existing shareholders, who plan to sell part of their stakes in the public market. The company announced the launch of the IPO in a separate statement, confirming that the shares will be listed in the United States. The filing did not disclose the exact number of shares or the final price range, which are typically set closer to the listing date.
Oura's decision to go public comes amid a broader reopening of the market for new listings. After a prolonged stretch in which many technology companies stayed private, the fall season is shaping up as a test of investor appetite for growth-oriented consumer hardware and health technology. A successful Oura offering could encourage other private companies to follow with their own listings.
The company has benefited from growing consumer interest in wearable health devices, a category that includes smartwatches, fitness bands and, increasingly, rings. Oura has carved out a niche by focusing on sleep and recovery metrics, and its products have been adopted by athletes, executives and others looking for continuous health data without a screen on their wrist.
Still, the IPO market remains selective. Investors have shown willingness to back companies with clear revenue growth and a defensible position in their market, but they have been less forgiving of businesses with uncertain paths to profitability. The filing does not include detailed financial results in the summary terms, and the company's valuation will ultimately depend on how investors assess its growth prospects against its costs.
The listing also puts a spotlight on the competitive landscape. Oura faces competition from larger technology companies that have expanded into health tracking, as well as from other startups pursuing similar form factors. Its ability to keep users engaged through subscription services and software updates will be a key part of the story it presents to public investors.
For the broader market, the Oura deal is one of several expected in the coming months. Bankers and investors have been watching for signs that the IPO window is opening more widely after a period of caution. A strong reception for Oura would be read as a positive signal for other companies considering listings before the end of the year.
The company's shareholders are seeking to raise up to $2.2 billion, a figure that would make the offering one of the larger technology listings of the season. The final size and pricing will depend on demand during the roadshow, and the shares are expected to begin trading after the offering is completed.
Oura has not yet set a date for the listing, and the filing notes that the terms remain subject to market conditions. The company's public debut will be closely watched as a gauge of investor enthusiasm for health-focused consumer hardware and for new issues more broadly.
6
